Treatment of Relapse of Small Cell Lung Cancer in Selected Patients with the Initial Combination Chemotherapy Carboplatin, Etoposide, and Epirubicin

Overview

Journal Thorax

Date 1992 May 1

PMID 1319088

Citations 1

Authors

P Collard

P Weynants

C Francis

D O Rodenstein

Affiliations

Soon will be listed here.

Abstract

Background: Relapse of small cell lung cancer is not usually treated with further chemotherapy as results are considered to be disappointing.

Methods And Results: Six patients with relapse of small cell lung cancer after a complete initial response and remission of more than one year responded to repeat treatment with the initial chemotherapy comprising carboplatin, etoposide, and epirubicin. The second remission ranged from six months to more than 15 months.

Conclusion: In patients with a relapse of small cell lung cancer after a complete initial response and prolonged remission retreatment with the initial combination chemotherapy cannot be dismissed and requires further study.

Citing Articles

Current concepts in the management of small cell lung cancer.

Ganti A, West W, Zhen W Indian J Med Res. 2013; 137(6):1043-51.

PMID: 23852285 PMC: 3734709.

References

Alexanian R, GEHAN E, Haut A, Saiki J, Weick J . Unmaintained remissions in multiple myeloma. Blood. 1978; 51(6):1005-11. View

Batist G, Ihde D, Zabell A, Lichter A, Veach S, Cohen M . Small-cell carcinoma of lung: reinduction therapy after late relapse. Ann Intern Med. 1983; 98(4):472-4. DOI: 10.7326/0003-4819-98-4-472. View

Crompton G . Small cell lung cancer. BMJ. 1990; 300(6719):209-10. PMC: 1662063. DOI: 10.1136/bmj.300.6719.209. View

Spiro S, Souhami R . Duration of chemotherapy in small cell lung cancer. Thorax. 1990; 45(1):1-2. PMC: 475628. DOI: 10.1136/thx.45.1.1. View

Spiro S, Souhami R, Geddes D, Ash C, Quinn H, Harper P . Duration of chemotherapy in small cell lung cancer: a Cancer Research Campaign trial. Br J Cancer. 1989; 59(4):578-83. PMC: 2247136. DOI: 10.1038/bjc.1989.117. View

Byrne M, Van Hazel G, Trotter J, Cameron F, Shepherd J, Cassidy B . Maintenance chemotherapy in limited small cell lung cancer: a randomised controlled clinical trial. Br J Cancer. 1989; 60(3):413-8. PMC: 2247200. DOI: 10.1038/bjc.1989.296. View

Postmus P, Berendsen H, van Zandwijk N, Splinter T, Burghouts J, Bakker W . Retreatment with the induction regimen in small cell lung cancer relapsing after an initial response to short term chemotherapy. Eur J Cancer Clin Oncol. 1987; 23(9):1409-11. DOI: 10.1016/0277-5379(87)90128-3. View

Seltzer V, Vogl S, Kaplan B . Recurrent ovarian carcinoma: retreatment utilizing combination chemotherapy including cis-diamminedichloroplatinum in patients previously responding to this agent. Gynecol Oncol. 1985; 21(2):167-76. DOI: 10.1016/0090-8258(85)90249-5. View

Wendt A, Jones S, Salmon S . Salvage treatment of patients relapsing after breast cancer adjuvant chemotherapy. Cancer Treat Rep. 1980; 64(2-3):269-73. View

10.

Buzdar A, Legha S, Hortobagyi G, Yap H, Wiseman C, Distefano A . Management of breast cancer patients failing adjuvant chemotherapy with adriamycin-containing regimens. Cancer. 1981; 47(12):2798-802. DOI: 10.1002/1097-0142(19810615)47:12<2798::aid-cncr2820471207>3.0.co;2-t. View

11.

Fisher R, DEVITA V, Hubbard S, Simon R, Young R . Prolonged disease-free survival in Hodgkin's disease with MOPP reinduction after first relapse. Ann Intern Med. 1979; 90(5):761-3. DOI: 10.7326/0003-4819-90-5-761. View

12.

Leonard R . Small cell lung cancer. Br J Cancer. 1989; 59(4):487-90. PMC: 2247163. DOI: 10.1038/bjc.1989.101. View

13.

Humblet Y, Weynants P, Bosly A, Majois F, Duprez P, Francis C . Carboplatin in association with etoposide and either adriamycin or epirubicin for untreated small cell lung cancer: a dose escalation study of carboplatin. UCL Clinical Oncology Group. Med Oncol Tumor Pharmacother. 1989; 6(3):207-12. DOI: 10.1007/BF02985192. View

14.

Giaccone G, Ferrati P, Donadio M, Testore F, CALCIATI A . Reinduction chemotherapy in small cell lung cancer. Eur J Cancer Clin Oncol. 1987; 23(11):1697-9. DOI: 10.1016/0277-5379(87)90452-4. View